Expertise in
21
conditions

Dr. Neal E. Dunlap

Radiation Oncology
Uofl Health-Brown Cancer Center
529 S Jackson St, 
Louisville, KY 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
21
conditions
Uofl Health-Brown Cancer Center
529 S Jackson St, 
Louisville, KY 

Overview

Neal Dunlap is a Radiation Oncologist practicing medicine in Louisville, Kentucky.

Dr. Dunlap is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).

He is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 24 clinical trials. Dr. Dunlap is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Internal Medicine in OH

Hospital Affiliations

University Of Louisville Hospital
UOFL HEALTH - JEWISH HOSPITAL And Mary & Elizabeth Hospital
Baptist Health Hardin

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baptist Health
  • HMO
  • INSURANCE PLAN
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Uofl Health-Brown Cancer Center
529 S Jackson St, Louisville, KY 40202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

24 Clinical Trials

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Enrollment Status: Recruiting
Publish Date: August 17, 2026
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 2/Phase 3
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Enrollment Status: Suspended
Publish Date: September 04, 2026
Intervention Type: Procedure, Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Suspended
Publish Date: September 01, 2026
Intervention Type: Procedure, Drug, Other, Radiation, Biological
Study Drugs: Atezolizumab, Cetuximab, Cisplatin, Docetaxel
Study Phase: Phase 2/Phase 3
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2026
Intervention Type: Radiation, Drug, Other, Procedure
Study Drugs: Carboplatin, Cisplatin, Docetaxel
Study Phase: Phase 2
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Radiation
Study Phase: Phase 1
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
View 9 Less Clinical Trials

83 Total Publications

Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.
Journal: The Journal of clinical investigation
Published: May 19, 2026
Similar Doctors
Expertise in
23
conditions
Dr. John A. Cox
Radiation Oncology
Expertise in
23
conditions
Dr. John A. Cox
Radiation Oncology
Referral may be required

Floyd Memorial Hospital And Health Services

2210 Green Valley Rd, 
New Albany, IN 
 (6.4 miles away)
812-945-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Cox is a Radiation Oncologist practicing medicine in New Albany, Indiana. Dr. Cox is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Cox is currently accepting new patients.

Expertise in
24
conditions
Dr. Shiao Y. Woo
Radiation Oncology
Expertise in
24
conditions
Dr. Shiao Y. Woo
Radiation Oncology
Referral may be required

Office

529 S Jackson St, 
Louisville, KY 
 (0.1 miles away)
502-561-2700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shiao Woo is a Radiation Oncologist practicing medicine in Louisville, Kentucky. Dr. Woo is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Endovascular Embolization, and Laminectomy. Dr. Woo is currently accepting new patients.

Expertise in
20
conditions
Dr. Crystal H. Mcmahan
Radiation Oncology
Expertise in
20
conditions
Dr. Crystal H. Mcmahan
Radiation Oncology
Referral may be required

Baptist Health Louisville

4000 Kresge Way, 
Louisville, KY 
 (5.7 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Crystal Mcmahan is a Radiation Oncologist practicing medicine in Louisville, Kentucky. Dr. Mcmahan is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Angiosarcoma. Dr. Mcmahan is currently accepting new patients.

Frequently Asked Questions about Dr. Neal E. Dunlap

How do I make an appointment with Dr. Neal E. Dunlap?

You can book an appointment with Dr. Neal E. Dunlap by calling their office at 502-562-4673. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Neal E. Dunlap a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Neal E. Dunlap is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Neal E. Dunlap specialize in?

While Dr. Neal E. Dunlap is a Radiation Oncology, they have specific expertise in Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Neal E. Dunlap participate in research or clinical trials?

Yes. Dr. Neal E. Dunlap has published 83 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Neal E. Dunlap's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Neal E. Dunlap accept my insurance?

Dr. Neal E. Dunlap accepts most major insurance plans, including Anthem BCBS and Baptist Health. We recommend calling the office directly at 502-562-4673 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dunlap's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile